<DOC>
	<DOCNO>NCT01854866</DOCNO>
	<brief_summary>Malignant ascites pleural effusion common symptom patient advanced cancer . Currently , management malignant ascites pleural effusion considerable clinical challenge . The investigator hypothesize tumor cell-derived microparticles package chemotherapeutic drug might useful mean treat malignant ascites pleural effusion . Thirty malignant ascites pleural effusion patient recruit Phase II clinical trial .</brief_summary>
	<brief_title>Safety Effectiveness Study Tumor Cell-derived Microparticles Treat Malignant Ascites Pleural Effusion</brief_title>
	<detailed_description>Ascites pleural effusion first remove patient . The patient locally injected microparticles package chemotherapeutic drug 4 time week . The therapeutic effect side effect record .</detailed_description>
	<mesh_term>Pleural Effusion</mesh_term>
	<mesh_term>Ascites</mesh_term>
	<mesh_term>Pleural Effusion , Malignant</mesh_term>
	<criteria>Clinical diagnosis malignant ascites malignant pleural effusion Nonmalignant ascites pleural effusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Pleural Effusion</keyword>
	<keyword>ascites</keyword>
	<keyword>Malignant</keyword>
</DOC>